Read more #IgAN #Nephrology #KidneyDisease #ClinicalResearch #CRO #RenalTrials #DrugDevelopment #eGFR To view or add a comment, sign in 19,626 followers
The mutation of GLP-1 positions 16, 17, 18, and 20 into Ala showed minor effects (IC 50 from 0.27 nM to 1.7, 0.46, 0.68, and 1.7 nM
The expected skin-related changes from a consistent CJC-1295/Ipamorelin protocol include increased skin thickness, firmer texture, improved elasticity, and a more even surface appearance
This consistency across nearly all patients suggests that when properly dosed and supported, these medications can address fundamental biological barriers to weight loss
For someone with dry skin who hates heavy, suffocating formulas, this was a huge win